has been frequently detected in bile samples, to date H. bilis-16S rRNA genes have only been detected in two cases, and H. hepaticus has not been detected [15] . These papers indicate that enterohepatic Helicobacter spp. may also infect in the human.
The aim of this study was to directly detect enterohepatic Helicobacter spp. from human bile samples. We cultured bile samples taken from patients with and without hepatobiliary diseases to determine whether Helicobacter spp. were present. We used PCR and nested-PCR for detecting H. hepaticus or H. bilis. As nested-PCR for only H. hepaticus was positive, we tested the bile samples for in situ hybridization by a probe for H. hepaticus and for Western blotting by anti-H. hepaticus antibodies.
Materials and Methods

Bile Samples
This study was approved by the Regional Ethics Committee of Miyoshi Central Hospital and all patients provided informed consent. The final clinical diagnoses of the patients were based on clinical imaging findings including endoscopic retrograde cholangiopancreatography, ultrasonogram, and computed tomography or surgery. Diagnoses included cholelithiasis (n = 60; mean age 61.2 years from 26 men and 34 women), cholecystitis and gastric cancer (n = 28; mean age 71.8 years from 19 men and 9 women), gallbladder polyp (n = 6; mean age 57.2 years from one man and five women), or other nonbiliary diseases (n = 32; mean age 69.2 years from 17 men and 15 women). We collected a total 126 bile samples from 63 men and 63 women (mean age 65.5 years) who underwent surgery, endoscopic retrograde cholangiopancreatography, percutaneous transhepatic cholangiography and drainage, or percutaneous transhepatic gallbladder drainage. Bile samples were stored at )80°C until processing and testing.
Bacterial Strains
Helicobacter pylori (ATCC 43504, American Type Culture Collection) were cultured on brain heart infusion (BHI) agar supplemented with 7% sterile defibrinated horse blood at 37°C in a microaerobic chamber (10% CO 2 , 5% O 2 , and 85% N 2 ). Helicobacter hepaticus (ATCC 51448) and H. bilis (ATCC 51630) were cultured under microaerobic conditions using GasPak Plus Hydrogen + CO 2 system without catalyst (3% H 2 , 10% CO 2 , 5% O 2 , 82% N 2 ) (BD JAPAN, Tokyo, Japan). The morphology (coccoid or rod form) of H. pylori was observed following culture for a period of 3 days to 2 weeks using Gram staining. Due to their slow growth rates, the morphology of H. hepaticus and H. bilis (coccoid or rod form) were observed using Gram staining following culture for between 1 and 4 weeks.
Cultures
Bile samples (1 mL) were passed through a Millipore Filter (0.45 lm pore size, 47 mm diameter) (Millipore Filter Corp., Billerica, MA, USA) by suction. Based on the fact that ammonium sulfate has been shown to allow the coccoid form of H. pylori to go into the logarithmic phase [16] and that bovine serum albumin is a supplement used for the growth of H. pylori [17] , the filter was washed under suction using 10 mL of 10 mmol ⁄ L ammonium sulfate, 10 mmol ⁄ L NaHCO 2 containing 0.9% deoxycholic acid, or phosphatebuffered saline (PBS) containing 0.1% bovine serum albumin. Following washing the filters from all 126 bile samples were placed onto BHI blood agar plates and incubated at 37°C in a microaerobic condition as previously described for 7 days. In addition, a portion of 5-10 lL of bile samples was directly inoculated and incubated on a BHI blood agar plate.
PCR Amplification
DNA was purified from 100 lL of bile sample using MagExtractor (TOYOBO Co. Ltd, Osaka, Japan). Primers for H. bilis, H. hepaticus, and Helicobacter universal primers were designed by modification of primers which were previously reported from Goto et al. [18] ( Table 1) . PCR reactions were conducted in an iCycler R (BioRad, Hercles, CA, USA). Reaction mixtures (50 lL of total volume) contained 1 lmol ⁄ L of oligonucleotide primer, 1· PCR buffer (EX Taq buffer), 1 U of EX Taq polymerase (TAKRA Bio Inc., Osaka, Japan), and 100 ng of template DNA, unless otherwise stated.
Nested PCR was performed on template DNA from bile samples using H. bilis or H. hepaticus specific primers. The second PCR primers were designed to lie within the PCR products of the Helicobacter universal primers. The first PCR reaction using Helicobacter universal primers for the DNA samples were preheated at 98°C for 2 minutes and then subjected to 30 cycles consisting of denaturation at 98°C for 10 seconds, primer annealing at 55°C using Helicobacter universal primers for 30 seconds, and extension at 72°C for 1 minute. The second PCR reaction individually used primers for H. hepaticus or H. bilis, with 5 lL of PCR products from the first PCR, was preheated at 98°C for 2 minutes and then subjected to 30 cycles consisting of denaturation at 98°C for 10 seconds), primer annealing at 55°C using H. hepaticus primers or H. bilis primers for 30 seconds, and extension at 72°C for 30 seconds. Samples of 10 lL were separated by electrophoresis on a 2% of NuSieve agarose gel (FMC Bioproducts Inc., Rockland, ME, USA), stained with ethidium bromide, and visualized under ultraviolet light.
In situ Hybridization
In situ hybridization was performed on nylon membrane using a 3¢-Cy3 labeled DNA probe (GAA ACT GTT ACT CTG GAG TGT GGG AGA GGT) for position 575-604 of the 16S rRNA gene of H. hepaticus. Bile samples (100 lL) were diluted to 10-fold with PBS and were adhered by suction to the nylon membrane using the Bio-Dot TM vacuum blotter (BIO-RAD). The membrane was prehybridized with calf thymus DNA in hybridization buffer containing 5· SSPE (0.2 mol ⁄ L phosphate buffer, pH 7.4, 2.98 mol ⁄ L sodium chloride, 0.02 mol ⁄ L EDTA), 5· Denhalrdt's solution, and 0.5% SDS for 1 hour. Hybridization with the probe was performed at 60°C for 18 hours in a water bath. After hybridization, the membrane was washed three times in 0.2· SSPE containing 0.1% SDS (each wash for 15 minutes at 65°C) to remove a nonspecific binding. The membrane was observed and photographed using a Leitz Vario-Orthomat Camera System (Ernst Leitz, Wetzlar, Germany).
Western Blotting
To prepare for cell lysates for Western blot analysis, bacteria were cultured in BHI medium with 5% horse serum in a microaerobic jar with continuous shaking for 5 days for H. pylori and 10 days for H. hepaticus. Cells were collected by centrifugation at 6400 · g for 20 minutes. Bacterial cells were washed with PBS and lysed by ultrasonication by ASTRASON W-380 ultrasonic processor (Heat System-Ultrasonics Inc., Farmingdale, NY, USA) in distilled water containing 1 mmol ⁄ L of phenylmethylsulfonyl fluoride for 20 minutes. The cell sediment was centrifuged at 44,280 · g for 30 minutes, and then the supernatant was used for Western blot analysis.
Western blotting was performed as previously described [19] . Bacterial lysates (1 mg ⁄ mL) of H. pylori or H. hepaticus were subjected to SDS-PAGE and transferred to PVDF membranes (Millipore Filter Corp.). The membranes were incubated with the 126 bile samples (1 : 100 dilutions) followed by peroxidase-labeled rabbit anti-human immunoglobulin G (IgG) antibody (DAKO, Japan, Tokyo) as secondary antibody. Blots were visualized using ECL TM Western blotting detection reagents (GE Healthcare Japan, Tokyo). The luminol reaction was detected with a LAS-1000mini Bio-Imaging Analyzer System (Fuji Photo Film Co., Tokyo).
Survival of Viable H. hepaticus in Bile Samples
Helicobacter hepaticus (approximately 1 · 10 6 CFU ⁄ mL in 50 lL) were inoculated into a 24-well culture plate with 450 lL of PBS, 0.9% deoxycholic acid in PBS, or in human bile samples obtained from three different persons. Bacteria were incubated at 37°C in 10% CO 2 incubator under100% humidity. Following incubation for 1, 3, 6, and 24 hours, 10lL samples from each well were inoculated onto BHI agar containing 5% horse blood. Plates were incubated at 37°C in microaerobic condition using GasPak Plus Hydrogen plus CO 2 system without catalyst for 7 days, and the colonies were counted. Two independent experiments were conducted with each sample being tested in triplicate.
Statistical Analysis
The association between H. hepaticus infected samples by patient disease type (cholelithiasis, cholecystitis with 
Results
Culture
After 7 days incubation, the surface of the cultured membrane was scraped and Gram staining was performed. However no spiral shaped Gram-negative bacteria were observed by microscopy. In addition, cells from the membrane were subcultured onto BHI blood agar plates and incubated under microaerobic conditions at 37°C for 7 days. The majority of colonies that grew on these plates were Escherichia coli or Enterococcus spp. Suspicious colonies which looked like members of the Helicobacter genus were further subcultured onto BHI blood agar; however, no enterohepatic Helicobacter were cultured.
PCR
We prepared three sets of primers: Helicobacter universal, H. hepaticus, and H. bilis (Table 1) . To confirm the specificity of the primers, DNA purified from H. pylori, H. hepaticus, and H. bilis was amplified using these three primer sets. When universal Helicobacter primers were used a 781-bp fragment was amplified from template DNA obtained from H. pylori, H. bilis, and H. hepaticus. The primer sets for H. bilis and H. hepaticus were both shown to be specific amplifying a 418-bp and a 458-bp fragment, respectively (data not shown). The sensitivity of the H. hepaticus-specific primers was confirmed. DNA was extracted from serial dilution of a 100-lL sample of H. hepaticus culture (10 7 to 10 cells ⁄ mL in TE buffer) by boiling at 100°C for 5 minutes. The DNA was amplified by PCR using H. hepaticus primers. PCR products were detected in samples that contained >10 5 cells ⁄ mL (Fig. 1A) . In addition, we performed nested PCR first using Helicobacter universal primers followed by H. hepaticus-specific primers. Using nested PCR, we were able to detect H. hepaticus purified DNA from samples containing <10 cells ⁄ mL (Fig. 1B ). The sensitivity of the H. bilis PCR was the same as that reported for the H. hepaticus PCR (data not shown). To detect H. hepaticus and H. bilis in bile samples PCR was conducted using Helicobacter universal primers as well as the H. hepaticus or H. bilis primers. Eight samples were positive for the first PCR using Helicobacter universal primer, but no products were observed by first PCR using H. hepaticus or H. bilis-specific primer. Nested PCR on the PCR products of the Helicobacter universal primers using the H. hepaticus or H. bilis primers detected only H. hepaticus DNA, with 16 of the 126 bile samples being positive for H. hepaticus ( Table 2 ). Examples of positive and negative samples in the PCR are shown in Fig. 1C . These positive samples did not correspond to the eight samples which were positive by PCR using Helicobacter universal primers. PCR products of H. hepaticus (405 bp) were sequenced and confirmed to be 100% identical to H. hepaticus 16S ribosormal RNA sequence.
In situ Hybridization
Morphology of H. pylori was observed by Gram staining after 5 days and 2 weeks incubation. As H. hepaticus, and H. bilis grow more slowly than H. pylori, morphologies of H. hepaticus, and H. bilis were observed after 7 days and 2 weeks. Helicobacter pylori retained its spiral H. hepaticus DNA was detected in samples contained with <10 cultured cells ⁄ mL by nested PCR when we employed for the first PCR using Helicobacter universal primers and for the second PCR using hepaticus specific primers. (C) Helicobacter hepaticus DNA purified from bile samples was detected by nested PCR. PCR reactions were curried out two concentrations of DNAs, sample b is diluted sample a by 10 times, purified from bile samples. Positive cases for H. hepaticus were no. 63, no. 68, no. 70. Positive controls were shown in right side.
morphology for 5 days (Fig. 2A1 ), however after 7 days incubation the coccoid form started to appear, and by 2 weeks all cells were in the coccoid form (Fig. 2A2) .
Morphologies of H. hepaticus and H. bilis kept spiral shaped within 10 days incubation (Fig. 2B1, C1) . Coccoid forms of H. hepaticus and H. bilis were appeared after 2 weeks incubation. The coccoid forms of three bacteria had similar morphologies in three strains (Fig. 2A2, B2 , and C2). The cultured bacteria were transferred to nylon membranes, and hybridized to an H. hepaticus probe. The H. hepaticus probe reacted with the logarithmic phase (spiral-shaped) bacteria and with coccoid forms of H. hepaticus (Fig. 2D1, D2 ). However the probe did not react with H. bilis and H. pylori. Bile samples were adhered to membranes and reacted with the probe. We observed positive reactions in 25 ⁄ 126 samples ( Table 2 ). All of positive samples were in the coccoid form (Fig. 2E ). Figure 2 Helicobacter hepaticus was detected by in situ hybridization. Morphology was observed after Gram staining of H. pylori (A1: 5 day culture and A2: 2 week culture), H. hepaticus (B1: 7 day culture and B2: 2 week culture) or, H. bilis (C1: 7 day culture and C2 2 week culture). Cultured H. hepaticus was adhered to a 0.45-mm nylon membrane (D1: 7 day culture and D2: 2 week culture as positive controls). Membranes were hybridized using a cy-3-labeled anti-H. hepaticus 16S ribosormal RNA probe was hybridized to bacterial RNA. Morphology was observed by a fluorescent microscopy. (E): A positive bile sample. 
Western Blotting
H. hepaticus Positive samples
H. hepaticus
Survival of Viable H. hepaticus in Human Bile
Survival of H. hepaticus in human bile was evaluated. After 1 hour, CFU of H. hepaticus in PBS had not decreased. However, CFU of H. hepaticus were markedly decreased after 3 hours, and no colony was detected after 5 hours. In contrast, CFU of hepaticus in both bile samples and 0.9% deoxycholic acid decreased after 1 hour (Fig. 4) .
Disease Specificity
The percentage of H. hepaticus-positive samples by each method (PCR, in situ, and Western blotting) are shown in Table 2 . We determined samples as H. hepaticuspositive if at least one of the three methods is positive. The ratio of H. hepaticus-positive samples in various diseases was shown in Table 3 . The percentage of patients that were H. hepaticus positive was significantly higher (p = .029) in those with cholelithiasis (41%) and cholecystitis and gastric cancer (36%) compared with those with gallbladder polyps (17%) and other diseases (13%).
Discussion
In general culture of Helicobacter species and in particular nonpylori Helicobacters is difficult. Indeed, we are unaware of any reports of the culture of Helicobacter species from human bile. Despite prolonged incubation and washing the membrane adhered samples with buffer to prevent toxicity from deoxycholic acid and chenodeoxycholic acid all of our culture attempts were negative for Helicobacter species. Based on our in situ hybridization studies it was clear that the majority of H. hepaticus in bile samples were in the coccoid form and that the numbers present were low. Given this, we speculate that isolation of logarithmic phase of H. hepaticus from humans may require the use of substantial liver samples, gallbladder mucosa, or intestinal mucosa. Seropositivity for H. hepaticus and H. bilis has been reported in humans. However, there is cross-reactivity among H. bilis, H. hepaticus, and H. pylori. Nilsson et al. showed elevated serum antibodies to H. hepaticus as measured by ELISA after a preabsorption step using H. pylori antigens, among patients with chronic liver disease [20] . Patients with chronic liver disease have increased antibody responses to H. hepaticus and H. bilis in patients compared to general population adults and blood donors, and cross-reactivity between H. bilis and H. pylori was also reported [21] . In this study, our detection of increased antibody responses to H. hepaticus with Western blotting analysis showed that IgG antibody to H. hepaticus was reacted with 90-kDa and ⁄ or 70-kDa bands in the positive samples. In contrast, positive cases for H. pylori reacted with some major H. pylori antigens which were detected as CagA, HSP60, Urease A and B subunit, or 25 kDa protein. Vorobjova et al. indicated that H. hepaticus-positive sera reacted with a 60-kDa band (heat shock protein) after absorption by H. pylori antigen [22] . Unfortunately, we could not measure serum antibodies, but this is similar to our results with bile samples and suggests that the IgG antibody in the bile may have originated from the serum.
The pathogenicity of H. hepaticus in humans remains obscure. Maurer 0 hour 1 hour 3 hours 5 hours Figure 4 Survival viable H. hepaticus in the biles H. hepaticus (approximately 1x10 6 CFU ⁄ mL in 50 lL) were incubated with 450 lL of PBS, 0.9% deoxycholic acid in PBS, or human bile samples, which were obtained from three different persons, at 1, 3 and 5 hours. CFU of H. hepaticus did not decrease for 1 hour in PBS. The viable bacteria markedly decreased in the PBS at 3 hours, and they were not detectable at 5 hours. Viable H. hepaticus in the bile samples were immediately decreased at 1 hour. enterohepatic Helicobacter spp. They reported that 40% of mice infected with H. hepaticus developed a cholesterol gallstone [23] . In our study, the prevalence of H. hepaticus infection in samples from patients with gallstones or cholecystitis was higher than in samples from patients with other diseases. Together these findings of both mice models and our human data suggest that H. hepaticus infection may contribute to the development of gallstones. While H. hepaticus was detected in bile samples only a limited number were present and these were in the coccoid form. We showed that high concentration of deoxycholic acid in bile might be toxic to viable H. hepaticus (Fig. 4) . Despite this, our results suggest that viable H. hepaticus may be able to infect the liver, gallbladder epithelium, or intestine of humans.
Although a high prevalence of H. hepaticus was detected in patients with cholelithiasis and cholecystitis we were unable to grow H. hepaticus from gallbladder bile samples. The mechanisms whereby gallstones develop are unknown but enterohepatic Helicobacter spp. may be closely associated with this disease in human.
